Back
4D Molecular Therapeutics Vs. Regeneron Pharmaceuticals, Inc. Industry Stock Comparison
Buy
69
FDMT
4D Molecular Therapeutics
Last Price:
$7.29
Seasonality Move:
-14.12%
Sell
50
REGN
Regeneron Pharmaceuticals, Inc.
Last Price:
$580.60
Seasonality Move:
4.63%
Buy
69
4D Molecular Therapeutics (FDMT)
is a Buy
Is 4D Molecular Therapeutics a Buy, Sell or Hold?
-
The current 4D Molecular Therapeutics [FDMT] share price is $7.26. The Score for FDMT is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
FDMT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Regeneron Pharmaceuticals, Inc. (REGN)
is a Sell
Is Regeneron Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Regeneron Pharmaceuticals, Inc. [REGN] share price is $580.41. The Score for REGN is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
REGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FDMT Stock Price Chart
What is 4D Molecular Therapeutics's stock price today?
-
The 4D Molecular Therapeutics share price today is $7.26Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FDMT is experiencing slight selling pressure.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals, Inc.'s stock price today?
-
The Regeneron Pharmaceuticals, Inc. share price today is $580.41Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing buying pressure, which is a positive indicator for future bullish movement.
FDMT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.69 | Buy |
Relative Strength Index (14 RSI): | 71.22 | Buy |
Chaikin Money Flow: | -42738 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.22 - 6.14) | Buy |
Bollinger Bands (100): | (3.03 - 4.95) | Buy |
REGN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 138.43 | Buy |
Relative Strength Index (14 RSI): | 60.8 | Buy |
Chaikin Money Flow: | 811127 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (549.15 - 568.53) | Buy |
Bollinger Bands (100): | (525.27 - 597.79) | Buy |
FDMT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.23 | Buy |
20-day SMA: | 5.41 | Buy |
50-day SMA: | 4.69 | Buy |
200-day SMA: | 5.01 | Buy |
8-day EMA: | 6.25 | Buy |
20-day EMA: | 4.58 | Buy |
50-day EMA: | 2.53 | Buy |
200-day EMA: | 0.76 | Buy |
REGN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 561.04 | Buy |
20-day SMA: | 560.6 | Buy |
50-day SMA: | 542.61 | Buy |
200-day SMA: | 647.25 | Sell |
8-day EMA: | 547.93 | Buy |
20-day EMA: | 423.6 | Buy |
50-day EMA: | 240.61 | Buy |
200-day EMA: | 73.24 | Buy |
4D Molecular Therapeutics Earnings Growth & FDMT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.28 per share, an increase next quarter of $0.29 per share, a decrease this year of $0.77 per share, and a decrease next year of $0.11 per share.
Regeneron Pharmaceuticals, Inc. Earnings Growth & REGN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.96 per share, an increase next quarter of $1.40 per share, a decrease this year of $5.50 per share, and an increase next year of $1.95 per share.
4D Molecular Therapeutics Technical Analysis
Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Regeneron Pharmaceuticals, Inc. Technical Analysis
Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |